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IN recent years the importance of cell-mediated allergic reactions against
grafted normal tissues and induced or transplanted tumours has received great
emphasis. However, the significance ofhumoral antibodies in either the rejection
ofnormal allogeneic tissue or in immune reactions to tumours cannot be dismissed
and in this connection it is important to have sensitive and reliable methods with
which to measure " tumour-specific " antibodies of the host animal. Cytotoxic
tests involving complement and the indirect immunofluorescent technique of
Coons are most frequently used in such studies. In this paper we report our use
of the mixed antiglobulin reaction to measure BP8 specific antibodies raised in
inbred C3H mice immunized against this tumour using formalized BP8 ascitic
tumour cells (of C3H origin). The sensitivity of the testing procedure was
compared with that of the immune cytolysis reaction.
MATERIAL AND METHODS
Mice
Inbred C3H mice were used for immunization and passage of the BP8 ascitic
tumour cells.
The BP8 tumour was first induced by benzopyrene in a C3H mouse in 1943 as
a solid sarcoma. It was later converted into an ascitic cell form which has been
maintained since by serial passage in C3H mice.
Formalin-treatment of BP8 cells
Tumour cells were harvested aseptically with a syringe from the abdominal
cavity ofmice, usually 8-12 days after passage and washed three times in buffered
saline. The deposited cells were resuspended in 1% neutral formalin-shaken
up and left exposed in this solution for 12-18 hours at +40 C. The treated cells
were then washed three times in saline and stored in 20% glycerol in saline at
-200 C.
For immunization or testing in the mixed antiglobulin reaction the frozen
formalin-fixed cells were thawed out and washed three times in saline.
Immunization of mice and challenge
Immunization.-Five million formalin-treated BP8 cells were injected intra-
peritoneally in C3H mice. One course consisted of four injections given at two
day intervals. Up to four courses were given with a week's interval in between.
Control mice were injected with buffered saline only.
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In other experiments 5 x 105 live unfixed cells were injected subcutaneously
on the back of the mice. A definite immunity against the ascitic form of the
tumour could be shown after spontaneous regression and disappearance of the
transient tumour growth at the site of injection.
Blood samples were collected at intervals by tail bleeding and the serum was
stored at -20° C. until tested.
For challenge after immunization, 5000 viable BP8 cells (either freshly
harvested from other mice or cells stored at -180° C. in a preserving medium:
14 ml. dimethyl sulphoxide, 20 ml. 5% methyl cellulose and Hanks salt solution
to 100 ml.) were injected intraperitoneally. As few as 100 cells were said to be
100% lethal with this tumour (Cater and Waldmann, 1967). In the present
experiments 5000 cells regularly killed C3H mice within 3 weeks and this dose was
used for challenge.
Detection of antibodies reacting with BP8 cells
Mixed antiglobulin reaction (see Coombs, 1968).-The indicator red cells were
sheep red cells sensitized with a 1/1000 dilution of mouse anti-sheep red cell serum
and subsequently washed twice. A rabbit anti-mouse y globulin serum (heated
at 560 C. and absorbed free of sheep red cell agglutinins) was used at a 1/250
dilution. This dilution produced macroscopic agglutination of the sensitized
red cells on a tile in 5 minutes.
To perform the test: Formalin-fixed tumour cells (300-500 cells/mm3) were
added in equal volume (2 drop amounts) to dilutions of heated mouse serum and
incubated at room temperature for an hour. The diluent for cells, serum and
washing the cells was Hank's balanced salt solution containing 0*1% bovine
serum albumin. After incubation the cells were washed twice, resuspended in
diluent and drop amounts added to ceramic ringed siliooned glass 3 in. x 2 in.
slides. Adrop ofantiglobulin reagent and sensitizedindicator cellswasthenadded
and after incubation in a moist chamber which was rocked, coverslips were added
and the test read under a phase-contrast microscope.
Immune cytolysis.-The serum was titrated on ringed siliconed glass slides,
a suspension of live BP8 cells (1 x 105 cells/ml.) in rabbit complement diluted
1/5 added to each drop. After incubation in a moist chamber at 370 C. for
12 hours coverslips were added and the reaction read under the phase microscope
for cytolysis (Spooner, Bowden and Carpenter, 1965).
RESULTS
Detection of humoral antibody
The level of antibody detected by the mixed antiglobulin reaction after 1, 2,
3 and 4 courses of immunization with formalin-treated BP8 cells is recorded in
Table I.
Even after two courses, antibody could not be consistently shown and such
animals showed little protection on challenge. After 4 courses antibody was
shown in all animals and as may be seen from Fig. 1 such animals had a definite
immunity to the challenge with live cells. After the challenge with live BP8 cells
the antibody level in the mice showed a further rise (Table I).
Sera from mice immunized by subcutaneous injection oflive BP8 cells (Fig. 3)
consistently showed a humoral antibody titre of 25 or 100.
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TABLE I.-Increase of the Titre ofAntibodies to BP8 Cells Following
Repeated Immunizing Injections
Titre of antisera against BP8 ascites
tumour cells (mixed antiglobulin test)
Sera tested after A __ _
1 course of immunization . 0 (10) (10)
2 courses of immunization . . 0 10 (100)
3 courses of immunization . 10 (100) 100
4 courses of immunization . 100 100 250
Rejection phenomenon . 250 250 1250
1. Each value shows the titre of the pooled serum from three mice.
2. Figures in parentheses show weakly positive reaction at each dilution, e.g. (100) indicates
"weak positive " at the dilution x 100. The results were always definitely positive with less diluted
sera, before the end-point.
The results with the mixed antiglobulin test were clear cut (Fig. 4 and 5).
Clear negative tests were obtained with most control sera even when tested
undiluted. However, sera collected from particular litters showed a very weak
reaction when tested undiluted or 2. The fact that these weak reactions seemed
to be confined to the sera of particular litters suggests that they were due to
naturally existing antibodies.
All sera, except one, tested by immune cytolysis failed to show any antibody.
The one serum with demonstrable cytotoxic antibody was that shown in Table I
with the titre of 1250 by the mixed antiglobulin reaction. The cytotoxic titre was
32. Using a rabbit anti-BP8 serum to control the cytotoxic tests the system
was shown to be reacting optimally. This cytotoxic reaction is frequently in use
in this laboratory (Spooner et al., 1965). These results indicate the much greater
sensitivity of the mixed antiglobulin reaction in this particular system.
Immunization
Immunization withformalin-fixed tumour cells
An immunity to challenge with BP8 ascites tumour cells could be produced in
C3H mice after four courses of injection with formalin-fixed tumour cells.
In one experiment, consisting of 5 groups of 4 mice each, none of the animals
which had received 3 or 4 courses of injection took the challenging tumour cells,
while all the control and 1-course-group died within 3 weeks due to the ascitic
tumour. Three mice of the 2-course-group died of the tumour while the fourth
animal survived. Further experiments of the same design (4 groups of 3 mice
each and 2 control mice) confirmed the above findings (Fig. 1). After challenge,
animals which subsequently were shown to be immune usually showed a slight
swelling due to accumulation of ascites but this was temporary and soon
disappeared. These mice showed no tumour growth during several months of
observation.
The immunity developed could be shown to last for a considerable time and
subsequent challenge 10 and 25 weeks later failed to produce malignant growths
in the recipients with a few exceptions (Fig. 2).
Immunization by subcutaneous injection of live BP8 cells
Following rejection of cells injected subcutaneously the mice showed an
immunity to intraperitoneal challenge. Some examples are shown in Fig. 3.
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Intraperitoneal challenge of BP8 ascites
tumour cells
Immunization Weeks
o. of intraperitoneal 0 , 2 3
njections) :(A) (B) I. . ..
JJJJ JA1 IMJ JJJJ : . Animal I1
Animal 12 JJJJ JJJJ JJJ JJJJ
Animal 13 JJJJ JJJJ JJJJ
Animal 14 -JUl JJ liii JJJJ
Animal 21 Saline solution . Tumour death (control)
Animal 22 Saline solution Tumourdeath (control)
Animal 23 Saline solutionTmou d (control).
leath
FIa.I.-AnexperimentshowingimmunizationofC3Hmice withformalinized BP8ascitestumour
cells and the resistance of the mice againstthe tumour. The dark patch shows the gradeof
abdominal swelling due to ascites accumulation, the degree (height) and the duration
(breadth). At the point marked (A), pooled serum from the mice 11-14 showed existence
of anti-BP8 tumour antibodies. Titre: x 1250 by the mixed antiglobulin technique, x 32
by the cytotoxic technique. At the point marked (B), titres of the same tests were: x 250
by the mixed antiglobulin technique, negative by the cytotoxic technique.
a 2 3
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Weeks
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1 .1 1 11 1 1 1 1 1 1
Challenge(0I) Challenge(111)
Animal 31 -----------.---
Animal 32 2. .
Animal 33
Tumour death
Animal 34-
FIG. 2.-The results of repeated intraperitoneal challenge of previously immunized mice.
The mice used in this experiment had been given 4 courses of immunization previously.
The dark patch shows the grade of abdominal swelling due to ascites accumulation, the
degree (height) and the duration (breadth).
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At first the injected cells grew and formed solid swellings which could persist for
2-4 weeks. Later the tumours decreased in size, quite often being associated with
central ulceration. Finally the tumour completely disappeared leaving the
site covered with normal skin, usually by the end of the fifth week. The intra-
peritoneal challenge with live BP8 ascitic cells consistently failed to produce an
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FiG. 3.-Subcutaneous injection of BP8 ascites tumour cells and subsequent intraperitoneal
challenge (humoral antibodies were detected by the mixed antiglobulin technique at the
points marked (A), the titres were between x 25 and x 100).
ascitic growth (4 groups of 2 mice each). In one exceptional case (No. 87 in Fig.
3) a subcutaneous tumour suddenly began to develop, when the intraperitoneal
challenge was given, at the same site where the initial subcutaneous injection had
been made previously.
DISCUSSION
By the use of the mixed antiglobulin reaction, antibodies reactive with BP8
ascitic tumour cells have been successfully demonstrated in the sera of immunized
C3H mice-a strain which is syngeneic with the tumour, at least at the time the
EXPLANATION OF PLATE
Mixed antiglobulin reaction in detection of antibodies to BP8 tumour cells.
FIG. 4.-Negative reaction showing no mixed aggregates. Separate clumping ofthe sensitized
red-cell indicator system, absolutely free from BP8 ascites tumour cells.
FIG. 5.-Positive reaction: Very few tumour cells can be seen at a glance, although there are
many tightly encased (see arrows) within mixed aggregates.
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tumour was induced by benzopyrene. Many years have, of course, elapsed since
the tumour was induced and the antibodies measured may be against acquired
antigens which are not specific tumour antigens. Nor can it be certain that the
immunity shown in the injected mice is due to the antibodies measured. All
that can be said is that their presence correlated well in time with the state ofresis-
tance to challenge with the tumour.
Many of the attempts to demonstrate humoral antibodies against tumours
(Klein and Klein, 1964; Stuck, Boyse, Old and Carswell, 1964; Lejneva, Zilber,
and Levleva, 1965; Pasternak, 1965; Apffel and Peters, 1967; Baldwin and Barker,
1967; and others) have been made using fluorescent antibody techniques and
immune cytolytic reactions. In the present study immune cytolysis proved to be
much less sensitive than the mixed antiglobulin reaction (see also SellandSpooner,
1966). The fluorescent antibody test is also likely to be much less sensitive than
the mixed antiglobulin reaction where antibodies to membrane antigens are
concerned. However the fluorescent antibody technique alone is suitable for
detecting antibodies to cytoplasmic antigens and for such situation is unrivalled.
When immunization against ascitic tumours is performed by way of intra-
peritoneal injection ofan antigenic preparation and evaluation is made by observa-
tion of growth inhibition of tumour cells transplanted into the abdominal cavity,
a question arises whether any inhibition ofgrowth is specific and allergic or due to
non-specific factors. For example simple injection of diluted formalin may
protect to some extent a host from subsequent intraperitoneal injection oftumour
cells. In the present experiments generalized allergic mechanisms must have been
responsible for the rejections since a similar immunity was produced by subcu-
taneous injection of tumour cells. The fact that BP8 ascitic tumour cells were
rejected when given to syngeneic mice by subcutaneous injection is comparable
with the result obtained by Apffel and Peters (1967). Subcutaneously injected
BP8 ascitic tumour cells seem to induce a rejection phenomenon due to tumour
specific antigens and leave antibodies against them in the host when spontaneously
rejected.
We have often used formalin-fixed tumour or other tissue cells in the mixed
antiglobulin reaction, but the use offormalin-fixed cells for immunization purposes
is of interest in the context of possible immunotherapy of cancer.
SUMMARY
1. C3H mice (originally syngeneic with BP8 tumour cells) may be immunized
against BP8 ascitic tumour by repeated intraperitoneal injection of formalin-
treated BP8 ascitic cells or by subcutaneous injection of live untreated BP8 cells.
2. In these immunized animals humoral antibodies reactive against BP8 cells
could be measured by the mixed antiglobulin reaction. The antibodies appeared
at the time the mice showed immunity to tumour challenge.
3. The mixed antiglobulin reaction proved to be much more sensitive than
immune cytolysis in detecting these antibodies.
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